About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors

Former President of BD North America brings global healthcare leadership experience as Selux launches its recently FDA-cleared NGP System for rapid antibiotic susceptibility testing.

Selux Diagnostics, a biotech startup in Boston whose mission is to combat superbug infections and antimicrobial resistance (AMR), announced today that healthcare industry veteran Jamie Condie has joined the company's Board of Directors. The announcement comes on the heels of U.S. Food and Drug Administration (FDA) clearance for Selux's proprietary Next Generation Phenotyping (NGP) System, a rapid antibiotic susceptibility (AST) testing platform that provides targeted therapeutic results days faster than the current standard of care.  

Condie recently retired as president of BD North America, a multinational medical technology company. He spent more than a decade in leadership positions at BD Diagnostics and Infectious Disease, the division focused on innovative solutions for microbiology labs and hospitals, including automated systems for the rapid identification of bacteria and detection of antimicrobial resistance.

"Selux has emerged as a clear leader in the global fight against antibiotic resistance by redefining the speed and performance of AST. I'm honored to be joining the organization at this exciting inflection point. With FDA clearance in hand, Selux can now share its Next Generation Phenotyping technology with the industry to transform the treatment of infectious disease," said Condie. 

Antimicrobial resistance is an important and urgent public health threat. New multi-drug resistant (MDR) bacteria continue to emerge, including a new strain of gonorrhea in Massachusetts found to be resistant to ciprofloxacin, penicillin, and tetracycline and that had reduced susceptibility to ceftriaxone, cefixime, and azithromycin. 

"Multi Drug Resistant infection is not only an antibiotic problem - it's a diagnostic problem. As we bring the fastest AST platform with a future-proof antibiotic menu to bear on this problem, we are fortunate to have Jamie join Selux's Board of Directors," said Steve Lufkin, CEO of Selux. "His extensive healthcare leadership experience and expertise will be invaluable as we move into this commercial phase."

The groundbreaking Selux NGP System holds the potential to save lives and decrease overreliance on broad-spectrum antibiotics, a key factor contributing to the rise of superbugs. In addition to raw speed, the system includes a comprehensive antibiotic menu that far surpasses the capabilities of current legacy AST systems, providing accurate, same-shift results for up to 50 antibiotics simultaneously with room to grow as new therapies become available. As a result, physicians can prescribe optimal treatment 3-5 days sooner, reducing hospital stays and de-escalating the cycle of antibiotic overuse and resistance.

For more information on the Selux NGP System, visit www.seluxdx.com.

About Selux Diagnostics 
Selux Diagnostics is a Boston-based biotech company focused on advancing science and technology to improve treatments and outcomes for infectious disease patients. By providing rapid Antibiotic Susceptibility Test (AST) results, Selux is combatting the superbug epidemic head-on. 

Their groundbreaking Next Generation Phenotyping (NGP) System can decrease the overreliance on broad-spectrum antibiotics, prepare for future bacteria evolution, and can accommodate new antibiotic therapies as they become available. This advance in diagnostics can save lives, allow physicians to prescribe personalized treatments 3-5 days sooner, and shorten hospital stays - providing better, faster care when you need it most. Learn more at seluxdx.com.

Contact Information:
Andrea LePain
andrea@emediajunction.com
617-894-1153


Original Source: Healthcare Industry Veteran Jamie Condie Joins Selux Diagnostics' Board of Directors
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.